X. Ye

发表

FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response.

Dan Yu, X. Ye, Ruixiang Che, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[Anti-tumor efficacy of P53 with 9R cell-penetrating peptides].

Yuquan Wei, N. Zhang, X. Ye, 2013, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.

X. Ye, J. Qi, G. Ren, 2014, Molecular immunology.

Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway

Dan Yu, X. Ye, Qiang Wu, 2016, Endocrine.

EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent

A. Tong, G. Guo, Xiaoling Li, 2016, International journal of nanomedicine.

[Optimization and characterization of a novel FGF21 mutant].

Dan Yu, X. Ye, G. Ren, 2012, Yao xue xue bao = Acta pharmaceutica Sinica.

Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice

Yingjie Zhang, X. Ye, Qiang Wu, 2015, Digestive Diseases and Sciences.

Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy.

Qingzhong Yu, X. Ye, J. Qi, 2016, Journal of pharmacological sciences.

Improving the specific antitumor efficacy of ONC by fusion with N-terminal domain of transferrin

Cunshuan Xu, X. Ye, J. Qi, 2018, Bioscience, biotechnology, and biochemistry.

FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy

Yuquan Wei, Dan Yu, X. Ye, 2016, Molecular and Cellular Biochemistry.

Fibroblast Growth Factor-21 Mediates Hepatic Glucose Metabolism of Type 1 Diabetes Model and Its Mechanism*: Fibroblast Growth Factor-21 Mediates Hepatic Glucose Metabolism of Type 1 Diabetes Model and Its Mechanism*

X. Ye, G. Ren, Deshan Li, 2011 .

Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.

Liming Xu, X. Ye, J. Qi, 2013, International immunopharmacology.

An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodies.

Dan Yu, X. Ye, Qiang Wu, 2019, International journal of biological macromolecules.

Pilot-scale production and characterization of PEGylated human FGF-21 analog.

Dan Yu, X. Ye, Qiang Wu, 2016, Journal of biotechnology.

Long-lasting hypoglycemic effect of modified FGF-21 analog with polyethylene glycol in type 1 diabetic mice and its systematic toxicity.

Dan Yu, X. Ye, Qiang Wu, 2016, European journal of pharmacology.

miR-541-3p Promoted Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) Replication by Targeting Interferon Regulatory Factor 7

Gaiping Zhang, Jing Chen, J. Qin, 2022, Viruses.

A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.

X. Ye, J. Qi, G. Ren, 2012, International immunopharmacology.

FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway.

Bing Zhou, X. Ye, G. Ren, 2014, Acta biochimica et biophysica Sinica.

A recombinant avian antibody against VP2 of infectious bursal disease virus protects chicken from viral infection.

Xiaomei Wang, X. Qi, X. Ye, 2017, Research in veterinary science.

Anchored periplasmic expression (APEx)-based bacterial display for rapid and high-throughput screening of B cell epitopes

X. Ye, G. Ren, Deshan Li, 2014, Biotechnology Letters.

Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy

Zhenyu Zhang, Qingzhong Yu, X. Ye, 2017, European journal of pharmacology.

Slc2a6 regulates myoblast differentiation by targeting LDHB

Y. Zhou, X. Ye, Ninghan Feng, 2022, Cell Communication and Signaling.

Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.

X. Ye, Qiang Wu, G. Ren, 2015, Journal of diabetes and its complications.

Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice

Dan Yu, X. Ye, Qiang Wu, 2015, Endocrine.

The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.

Dan Yu, X. Ye, Qiang Wu, 2016, Immunology letters.

FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy

Yuquan Wei, Dan Yu, X. Ye, 2016, Molecular and Cellular Biochemistry.

Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway

G. Wang, Wei Chen, Q. Zhai, 2021, Acta Pharmacologica Sinica.

Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.

Dan Yu, X. Ye, Qiang Wu, 2017, Journal of diabetes and its complications.

Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice.

Dan Yu, X. Ye, J. Qi, 2015, Diabetes & metabolism.

Stability and Glucose Regulation of FGF21 After Modified With Arginines*: Stability and Glucose Regulation of FGF21 After Modified With Arginines*

X. Ye, Deshan Li, Wen-Fei Wang, 2012 .

SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate

Xinmiao Liang, Dong Liu, Y. Zheng, 2021, International Journal of Biological Macromolecules.

Anchored periplasmic expression (APEx)-based bacterial display for rapid and high-throughput screening of B cell epitopes

X. Ye, G. Ren, Deshan Li, 2014, Biotechnology Letters.

A neutralization scFv antibody against IL-1β isolated from a NIPA-based bacterial display library.

Liming Xu, X. Ye, G. Ren, 2013, Current pharmaceutical biotechnology.